Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 5/20 | 0.38 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 4/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.34 |
| ▸ | DRD1 | P21728 | 4/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | CCR4 | P51679 | 1/20 | 0.31 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16175533 | 0.89 | NFE2L2 (0.41) | NFE2L2SSTR4HTR1ASLC6A2SLC6A4 | |
| SCHEMBL2301802 | 0.76 | NFE2L2 (0.36) | NFE2L2SSTR4HTR1ASLC6A2SLC6A4 | |
| SCHEMBL10324235 | 0.72 | SSTR4 (0.46) | NFE2L2SSTR4HTR1ASLC6A2SLC6A4 | |
| SCHEMBL3820870 | 0.72 | ALDH1A1 (0.39) | SSTR4HTR1ASLC6A2SLC6A4SLC6A3 | |
| SCHEMBL30038861 | 0.71 | — | — | |
| SCHEMBL1690288 | 0.71 | — | — | |
| SCHEMBL3706881 | 0.71 | DRD1 (0.43) | NFE2L2HTR1ASLC6A2SLC6A4SLC6A3 | |
| SCHEMBL11755561 | 0.70 | DPP4 (0.41) | NFE2L2SSTR4HTR1ASLC6A2SLC6A4 | |
| SCHEMBL10198277 | 0.69 | NFE2L2 (0.35) | NFE2L2HTR1ASLC6A2SLC6A4SLC6A3 | |
| SCHEMBL28080986 | 0.69 | SSTR4 (0.46) | NFE2L2SSTR4HTR1ASLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130109708-A1 | Chemical Compounds | PFIZER LIMITED (GB) | 2013-05-02 | — | — | US | disclosed |
| US-20120010183-A1 | Chemical Compounds | PFIZER LIMITED (GB) | 2012-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130109708-A1 | Chemical Compounds | SCN1A, SCN1B, SCN7A | NFE2L2 2744/4885SSTR4 3071/4885HTR1A 253/4885 |
| US-20120010183-A1 | Chemical Compounds | SCN1A, SCN1B, SCN7A | NFE2L2 3072/4885SSTR4 2859/4885HTR1A 170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.